SEC Form 4 · accession 0001127602-19-008807

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Feb 26, 2019

Accepted (ET)

Feb 28, 2019 · 9:51 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 26, 2019	S	300	$140.11	D	293,488	D
Common Stock	Feb 26, 2019	S	100	$140.12	D	293,388	D
Common Stock	Feb 26, 2019	S	11	$140.125	D	293,377	D
Common Stock	Feb 26, 2019	S	200	$140.14	D	293,177	D
Common Stock	Feb 26, 2019	S	90	$140.16	D	293,087	D
Common Stock	Feb 26, 2019	S	400	$140.19	D	292,687	D
Common Stock	Feb 26, 2019	S	40	$140.205	D	292,647	D
Common Stock	Feb 26, 2019	S	200	$140.22	D	292,447	D
Common Stock	Feb 26, 2019	S	30	$140.225	D	292,417	D
Common Stock	Feb 26, 2019	S	100	$140.24	D	292,317	D
Common Stock	Feb 26, 2019	S	30	$140.245	D	292,287	D
Common Stock	Feb 26, 2019	S	30	$140.255	D	292,257	D
Common Stock	Feb 26, 2019	S	200	$140.26	D	292,057	D
Common Stock	Feb 26, 2019	S	200	$140.27	D	291,857	D
Common Stock	Feb 26, 2019	S	30	$140.275	D	291,827	D
Common Stock	Feb 26, 2019	S	200	$140.28	D	291,627	D
Common Stock	Feb 26, 2019	S	110	$140.285	D	291,517	D
Common Stock	Feb 26, 2019	S	300	$140.29	D	291,217	D
Common Stock	Feb 26, 2019	S	200	$140.30	D	291,017	D
Common Stock	Feb 26, 2019	S	100	$140.315	D	290,917	D
Common Stock	Feb 26, 2019	S	102	$140.325	D	290,815	D
Common Stock	Feb 26, 2019	S	500	$140.33	D	290,315	D
Common Stock	Feb 26, 2019	S	200	$140.35	D	290,115	D

No Table II lines on this filing.